Literature DB >> 33484487

Visualization and Documentation of Capsule and Melanin Production in Cryptococcus neoformans.

Connie B Nichols1.   

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen primarily targeting immunosuppressed populations in both resource-rich and resource-limited nations. Successful treatment is limited to a few antifungals that have become compromised by cryptococcal resistance, leading to intensive research seeking new drug candidates. Two distinguishing hallmarks of this species are the ability to develop a polysaccharide capsule and melanization of the fungal cells. These also act as virulence factors, protecting this pathogen in the host as well as in the environment. Here we describe two classic methods to document capsule and melanin. Although initially described and documented several decades ago, these methods remain relevant in spite of the advent of more sophisticated methodology, due in part to their simplicity and cost efficiency.
© 2021 Wiley Periodicals LLC. Basic Protocol 1: Capsule visualization by India ink counterstaining Basic Protocol 2: Assessment of melanin on solid media Alternative Protocol: Quantification of melanin production in liquid medium. © 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Cryptococcus neoformans; fungal pathogen; melanin; polysaccharide capsule; virulence

Mesh:

Substances:

Year:  2021        PMID: 33484487      PMCID: PMC8323260          DOI: 10.1002/cpz1.27

Source DB:  PubMed          Journal:  Curr Protoc        ISSN: 2691-1299


  26 in total

Review 1.  Laccase and melanin in the pathogenesis of Cryptococcus neoformans.

Authors:  P R Williamson
Journal:  Front Biosci       Date:  1997-11-01

Review 2.  Virulence mechanisms and Cryptococcus neoformans pathogenesis.

Authors:  J Andrew Alspaugh
Journal:  Fungal Genet Biol       Date:  2014-09-23       Impact factor: 3.495

3.  Decreased susceptibility of melanized Cryptococcus neoformans to UV light.

Authors:  Y Wang; A Casadevall
Journal:  Appl Environ Microbiol       Date:  1994-10       Impact factor: 4.792

4.  Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Authors:  A Casadevall; W Cleare; M Feldmesser; A Glatman-Freedman; D L Goldman; T R Kozel; N Lendvai; J Mukherjee; L A Pirofski; J Rivera; A L Rosas; M D Scharff; P Valadon; K Westin; Z Zhong
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 5.  Combatting the evolution of antifungal resistance in Cryptococcus neoformans.

Authors:  Arianne Bermas; Jennifer Geddes-McAlister
Journal:  Mol Microbiol       Date:  2020-07-22       Impact factor: 3.501

6.  Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans.

Authors:  J C Rhodes; I Polacheck; K J Kwon-Chung
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Cryptococcus neoformans melanin and virulence: mechanism of action.

Authors:  Y Wang; P Aisen; A Casadevall
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 8.  Innate Immunity against Cryptococcus, from Recognition to Elimination.

Authors:  Althea Campuzano; Floyd L Wormley
Journal:  J Fungi (Basel)       Date:  2018-03-07

Review 9.  Present and Future Therapy of Cryptococcus Infections.

Authors:  Ahmad Mourad; John R Perfect
Journal:  J Fungi (Basel)       Date:  2018-07-03

Review 10.  Pathogenic Delivery: The Biological Roles of Cryptococcal Extracellular Vesicles.

Authors:  Haroldo C de Oliveira; Rafael F Castelli; Flavia C G Reis; Juliana Rizzo; Marcio L Rodrigues
Journal:  Pathogens       Date:  2020-09-16
View more
  2 in total

1.  Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising Candida albicans and/or Cryptococcus neoformans.

Authors:  Weidong Qian; Xinchen Li; Qiming Liu; Jiaxing Lu; Ting Wang; Qian Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-05-20       Impact factor: 6.073

2.  Phytochemical Analysis and Antifungal Potentiating Activity of Extracts from Loquat (Eriobotrya japonica) against Cryptococcus neoformans Clinical Isolates.

Authors:  Borel Ndezo Bisso; Prudence Ngalula Kayoka-Kabongo; Roland Tchuenteu Tchuenguem; Jean Paul Dzoyem
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.